Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Linz, Valerie Catherine; Liebau, Emma; Herrmann, Laura et al.
Association of preoperative G8 score with survival, preoperative anemia and vitamin D status in gynecologic cancer patients: 5-year analysis of the Frail-B studyGYNECOLOGIC ONCOLOGY. Bd. 205. 2026 S. 70-78
Harter, Philipp; Marme, Frederik; Redondo, Andres et al.
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III TrialJOURNAL OF CLINICAL ONCOLOGY. Bd. 44. H. 2. 2026
Flechtenmacher, Anna Sophia; Schiestl, Lina Judit; Singer, Susanne et al.
Sexual health of female breast cancer survivors and their partnersARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 313. H. 1. 2026
Perner, Florian; Berg, Tobias; Sasca, Daniel et al.
Therapeutic targeting of chromatin alterations in leukemia and solid tumorsINTERNATIONAL JOURNAL OF CANCER. Bd. 158. H. 2. 2026 S. 382-408
Toelle, Daniela; Ferner, Marion; Mai, Sandra Stephanie et al.
"Accompanying the dying process": A guide to dealing with the dying and their relativesDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 150. H. 14. 2025 S. 807-816
Fellmann, Cara Sophie; Rohner, Annika; Knoll, Katharina et al.
A DECADE OF CHANGE-ENDOMETRIAL CARCINOMA (EC) RISK CLASSIFICATION BEFORE, AFTER AND BEYOND TCGAINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 35. H. 11. 2025
Frenking, Jan H.; Riedhammer, Christine; Teipel, Raphael et al.
A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myelomaHEMASPHERE. Bd. 9. H. 4. 2025
Hess, Georg; Eyre, Toby A.; Jen, Min-hua et al.
A matching-adjusted indirect comparison of survival outcomes with pirtobrutinib (BRUIN) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitorBRITISH JOURNAL OF HAEMATOLOGY. 2025
El-Khoueiry, Anthony B.; Kim, Richard D.; Harris, William P. et al.
A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinomaHEPATOLOGY. 2025
Ferdinandus, Simone; Ruhle, Alexander; Lamrani, Allison et al.
Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter studyJOURNAL FOR IMMUNOTHERAPY OF CANCER. Bd. 13. H. 10. 2025